Walt Mossberg, technology columnist for the Wall Street Journal, broke the news this morning that Telcare's cellular-enabled blood glucose meter will become commercially available next week. (Assumedly timed to launch at CES, the big consumer tech event in Las Vegas.)
Mossberg, who has Type 2 diabetes, also gave the device an overall positive review with very few caveats.
Telcare BGM is a 3G-...
